UBS Group
CHAC.WS

UBS Group’s Chardan Healthcare Acquisition Corp. CHAC.WS Stock Holding History

UBS Group’s Portfolio CHAC.WS Stock Details CHAC.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-400
Closed – – 8764
2019
Q3 		$0 Hold
400
– – ﹤0.01% 8503
2019
Q2 		$0 Buy
+400
New +$175 ﹤0.01% 8411

UBS Group's CHAC.WS Position: Q4 2019 in Review

UBS Group sold out of Chardan Healthcare Acquisition Corp. (CHAC.WS) in Q4 2019, closing a stake of 400 shares.

UBS Group first reported a position in CHAC.WS in Q2 2019 and held it in 2 quarters. The position peaked at $0 in Q3 2019. 0 funds tracked by Wall St. Rank hold CHAC.WS as of Q4 2019.

  • UBS Group reported no remaining Chardan Healthcare Acquisition Corp. position as of Q4 2019 after selling out during the quarter.
  • UBS Group sold 400 Chardan Healthcare Acquisition Corp. shares in Q4 2019.
  • UBS Group first reported a position in Chardan Healthcare Acquisition Corp. in Q2 2019 and held it in 2 quarters.
  • UBS Group's Chardan Healthcare Acquisition Corp. position peaked at $0 in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition Corp. as of Q4 2019.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.